Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 14, 2021. Long positions only.
- Positions
- 54
- No 13F data for Q4 2020
- Portfolio value
- $168.4M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 794,186 | $50.1M | 29.8% | – | – | History |
| BDSXBiodesix Inc | COM | 1,104,953 | $22.4M | 13.3% | – | – | History |
| AXDXAccelerate Diagnostics, Inc | COM | 2,213,326 | $18.4M | 10.9% | – | – | History |
| NBIXNeurocrine Biosciences Inc | Stock | 80,200 | $7.80M | 4.6% | – | – | History |
| QDELQuidelOrtho Corp | COM | 58,644 | $7.50M | 4.5% | – | – | History |
| ACADAcadia Pharmaceuticals Inc | COM | 177,000 | $4.57M | 2.7% | – | – | History |
| FHTXFoghorn Therapeutics Inc. | COM | 314,143 | $4.14M | 2.5% | – | – | History |
| ALBOAlbireo Pharma, Inc. | COM | 111,000 | $3.91M | 2.3% | – | – | History |
| BIIBBiogen Inc. | COM | 12,100 | $3.38M | 2.0% | – | – | History |
| UTHRUnited Therapeutics Corp | COM | 18,000 | $3.01M | 1.8% | – | – | History |
| XLRNAcceleron Pharma Inc | COM | 18,672 | $2.53M | 1.5% | – | – | History |
| CGEMCullinan Therapeutics, Inc. | COM | 60,114 | $2.50M | 1.5% | – | – | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 230,000 | $2.42M | 1.4% | – | – | History |
| BLUEbluebird bio, Inc. | COM | 75,500 | $2.28M | 1.4% | – | – | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 300,000 | $1.86M | 1.1% | – | – | History |
| NKTRNektar Therapeutics | COM | 92,000 | $1.84M | 1.1% | – | – | History |
| MASIMasimo Corp | COM | 8,000 | $1.84M | 1.1% | – | – | History |
| IMGNImmunoGen, Inc. | COM | 190,000 | $1.54M | 0.9% | – | – | History |
| ChemoCentryx, Inc.16383L106 | COM | 30,000 | $1.54M | 0.9% | – | – | – |
| ARNAArena Pharmaceuticals Inc | COM NEW | 22,000 | $1.53M | 0.9% | – | – | History |
| BIORBiora Therapeutics, Inc. | COM | 270,000 | $1.28M | 0.8% | – | – | History |
| HROWHarrow, Inc. | COM | 180,000 | $1.22M | 0.7% | – | – | History |
| VNDAVanda Pharmaceuticals Inc. | COM | 80,000 | $1.20M | 0.7% | – | – | History |
| CORTCorcept Therapeutics Inc | COM | 50,000 | $1.19M | 0.7% | – | – | History |
| SLNOSoleno Therapeutics Inc | COM | 876,899 | $1.10M | 0.7% | – | – | History |
| ELTXElicio Therapeutics, Inc. | COM | 60,615 | $1.09M | 0.7% | – | – | History |
| ETRNMidstream Co LLC | COM | 133,050 | $1.09M | 0.6% | – | – | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 40,000 | $1.03M | 0.6% | – | – | History |
| CLRContinental Resources, Inc | COM | 38,600 | $999.0K | 0.6% | – | – | History |
| ARVNArvinas, Inc. | COM | 15,000 | $992.0K | 0.6% | – | – | History |
| GTHXG1 Therapeutics, Inc. | COM | 40,000 | $962.0K | 0.6% | – | – | History |
| CFRXCONTRAFECT Corp | COM | 200,000 | $960.0K | 0.6% | – | – | History |
| OVVOvintiv Inc. | COM | 34,350 | $818.0K | 0.5% | – | – | History |
| NARIInari Medical, Inc. | Stock | 7,000 | $749.0K | 0.4% | – | – | History |
| TGTXTG Therapeutics, Inc. | COM | 15,000 | $723.0K | 0.4% | – | – | History |
| AWHLAspira Women's Health Inc. | COM | 103,104 | $696.0K | 0.4% | – | – | History |
| BHVNBiohaven Ltd. | COM | 10,000 | $684.0K | 0.4% | – | – | History |
| PGNYProgyny, Inc. | COM | 15,000 | $668.0K | 0.4% | – | – | History |
| ALKSAlkermes plc. | SHS | 35,000 | $654.0K | 0.4% | – | – | History |
| PXDPioneer Natural Resources Co | COM | 3,800 | $604.0K | 0.4% | – | – | History |
| STOKStoke Therapeutics, Inc. | COM | 15,000 | $583.0K | 0.3% | – | – | History |
| XNCRXencor Inc | COM | 12,300 | $530.0K | 0.3% | – | – | History |
| LSFLaird Superfood, Inc. | COM STK | 14,000 | $525.0K | 0.3% | – | – | History |
| Translate Bio, Inc.89374L104 | COM | 30,000 | $495.0K | 0.3% | – | – | – |
| FOLDAmicus Therapeutics, Inc. | COM | 38,000 | $375.0K | 0.2% | – | – | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 8,000 | $343.0K | 0.2% | – | – | History |
| IFRXInflaRx N.V. | COM | 70,000 | $273.0K | 0.2% | – | – | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 9,000 | $260.0K | 0.2% | – | – | History |
| PTGXProtagonist Therapeutics, Inc | COM | 10,000 | $259.0K | 0.2% | – | – | History |
| DRNADicerna Pharmaceuticals Inc | COM | 10,000 | $256.0K | 0.2% | – | – | History |
| YTENYIELD10 Bioscience, Inc. | COM | 18,952 | $238.0K | 0.1% | – | – | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 20,000 | $203.0K | 0.1% | – | – | History |
| TXMDTherapeuticsMD, Inc. | COM | 100,000 | $134.0K | 0.1% | – | – | History |
| CNCEConcert Pharmaceuticals, Inc. | COM | 20,000 | $100.0K | 0.1% | – | – | History |